Case Study: Using Real-World Data to Expand Eligibility Criteria for Phase II Inflammation Trial Posted on June 8, 2021February 10, 2025 by Hannah Faulkner Case Study: Using Real-World Data to Expand Eligibility Criteria for Phase II Inflammation Trial
Quality by Design Maturity Model Posted on June 8, 2021February 10, 2025 by Hannah Faulkner Quality by Design Maturity Model
Executive Summary: Recommendations for Patient Group Engagement Posted on June 8, 2021February 7, 2025 by Hannah Faulkner Executive Summary: Recommendations for Patient Group Engagement
Flowchart: Steps For Novel Endpoint Development Posted on June 7, 2021January 31, 2025 by Hannah Faulkner Flowchart: Steps For Novel Endpoint Development
Detailed Steps for Novel Endpoint Development with Suggested Approaches & Considerations Posted on June 7, 2021January 31, 2025 by Hannah Faulkner Detailed Steps for Novel Endpoint Development with Suggested Approaches & Considerations
Digital Health Technologies Data Flow Diagram Posted on June 7, 2021February 6, 2025 by Hannah Faulkner Digital Health Technologies Data Flow Diagram
Decision Support Tool: Real-Time Data Sharing with Study Participants Posted on June 7, 2021February 6, 2025 by Hannah Faulkner Decision Support Tool: Real-Time Data Sharing with Study Participants
Recommendations for Registry Trials Posted on June 7, 2021February 11, 2025 by Hannah Faulkner Recommendations for Registry Trials
How to Identify and Prioritize Trial Stakeholders Posted on June 7, 2021February 10, 2025 by Hannah Faulkner How to Identify and Prioritize Trial Stakeholders
Should I Include Patient Reported Outcomes (PROs) in my Study? Posted on June 7, 2021February 10, 2025 by Hannah Faulkner Should I Include Patient Reported Outcomes (PROs) in my Study?
